76 Results

People

  1. Iasonos
    Iasonos
  2. Chi
    Chi
  3. Barakat
    Barakat
  4. Abu-Rustum
    Abu-Rustum
  5. Zhou
    Zhou
  6. Aghajanian
    Aghajanian
  7. Sonoda
    Sonoda
  8. Seshan
    Seshan
  9. Leitao
    Leitao
  10. Gardner
    Gardner

Groups

  1. Epidemiology and Biostatistics (76)
  2. Biostatistics Service (72)
  3. Gynecology Disease Management Team (69)
  4. Surgery (66)
  5. GDMT, Surgery (56)
  6. Department of Medicine (47)
  7. Solid Tumor Oncology Division (46)
  8. GDMT, Medicine (44)
  9. Gynecologic Medicine Service (44)
  10. Center for Pancreatic Cancer Research (25)
  1. "aged"
  2. "Journal article"
  3. "Epidemiology and Biostatistics"
  4. "Gynecologic Oncology"
Formats
  1. Journal Article (76)
Groups
  1. Epidemiology and Biostatistics (76)
  2. Biostatistics Service (72)
  3. Gynecology Disease Management Team (69)
  4. Surgery (66)
  5. GDMT, Surgery (56)
  6. Department of Medicine (47)

More Groups

People
  1. Alexia Iasonos (47)
  2. Dennis Chi (37)
  3. Richard Barakat (35)
  4. Nadeem Abu-Rustum (34)
  5. Qin Zhou (34)
  6. Carol Aghajanian (29)

More People

Years
  1. 2024 (3)
  2. 2023 (7)
  3. 2022 (1)
  4. 2021 (2)
  5. 2020 (7)
  6. 2019 (4)

More Years

Publications
  1. Gynecologic Oncology (76)
Publishers
  1. Elsevier Inc. (76)

Results (76)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer
    Journal Article

    Ehmann, S.; Lam, C.; Zhou, Q.; Iasonos, A.; Grisham, R. N.; Tew, W. P.; O'Cearbhaill, R. E.; Long Roche, K.; Zivanovic, O.; Sonoda, Y.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)
    Journal Article

    Lumish, M.; Chui, M. H.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Cohen, S.; Friedman, C.; Grisham, R.; Konner, J.; Kyi, C.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival
    Journal Article

    Kahn, R. M.; Selenica, P.; Boerner, T.; Roche, K. L.; Xiao, Y.; Sia, T. Y.; Maio, A.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study
    Journal Article

    Praiss, A. M.; Hirani, R.; Zhou, Q.; Iasonos, A.; Sonoda, Y.; Abu-Rustum, N. R.; Leitao, M. M. Jr; Long Roche, K.; Broach, V.; Gardner, G. J.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Leave it in the past - Primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study
    Journal Article

    Sia, T. Y.; Manning-Geist, B. L.; Ehmann, S.; Lavery, J. A.; Luardo, C.; Praiss, A.; Iasonos, A.; Sonoda, Y.; Grisham, R. N.; Liu, Y. L.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Impact of immune infiltration signatures on prognosis in endometrial carcinoma is dependent on the underlying molecular subtype
    Journal Article

    Dessources, K.; Ferrando, L.; Zhou, Q. C.; Iasonos, A.; Abu-Rustum, N. R.; Reis-Filho, J. S.; Riaz, N.; Zamarin, D.; Weigelt, B.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trial
    Journal Article

    Praiss, A. M.; Zhou, Q.; Iasonos, A.; Moukarzel, L.; Dessources, K.; Soldan, K.; Su, K.; Sonoda, Y.; Roche, K. L.; Gardner, G. J.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Dietary omega-3 fatty acids and endometrial cancer risk in the Epidemiology of Endometrial Cancer Consortium: An individual-participant meta-analysis
    Journal Article

    Brasky, T. M.; Hade, E. M.; Cohn, D. E.; Newton, A. M.; Petruzella, S.; O'Connell, K.; Bertrand, K. A.; Cook, L. S.; De Vivo, I.; Du, M.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level – A Memorial Sloan Kettering Cancer Center team ovary study
    Journal Article

    Kahn, R. M.; McMinn, E.; Yeoshoua, E.; Boerner, T.; Zhou, Q.; Iasonos, A.; Long Roche, K.; Zivanovic, O.; Gardner, G. J.; Sonoda, Y.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study
    Journal Article

    Rubinstein, M. M.; Doria, E. R.; Konner, J.; Lichtman, S.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Troso-Sandoval, T.; Friedman, C.; O'Cearbhaill, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save